Municipal Employees Retirement System of Michigan grew its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,737 shares of the health services provider’s stock after purchasing an additional 180 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in LHC Group were worth $1,045,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in LHCG. Freestone Capital Holdings LLC raised its position in LHC Group by 2.5% during the first quarter. Freestone Capital Holdings LLC now owns 4,181 shares of the health services provider’s stock valued at $464,000 after buying an additional 101 shares during the period. Bridge City Capital LLC increased its position in LHC Group by 0.5% in the 2nd quarter. Bridge City Capital LLC now owns 22,312 shares of the health services provider’s stock worth $2,668,000 after purchasing an additional 110 shares during the last quarter. HMS Capital Management LLC increased its position in LHC Group by 3.4% in the 2nd quarter. HMS Capital Management LLC now owns 3,531 shares of the health services provider’s stock worth $422,000 after purchasing an additional 115 shares during the last quarter. Arizona State Retirement System increased its position in LHC Group by 0.3% in the 1st quarter. Arizona State Retirement System now owns 45,057 shares of the health services provider’s stock worth $4,995,000 after purchasing an additional 123 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its position in LHC Group by 1.2% in the 2nd quarter. State of Alaska Department of Revenue now owns 9,968 shares of the health services provider’s stock worth $1,191,000 after purchasing an additional 123 shares during the last quarter. 91.74% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ:LHCG opened at $120.82 on Thursday. The firm’s 50 day simple moving average is $122.32. LHC Group, Inc. has a twelve month low of $80.84 and a twelve month high of $129.37. The company has a market cap of $3.70 billion, a P/E ratio of 34.03, a price-to-earnings-growth ratio of 1.95 and a beta of 0.84. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.57 and a current ratio of 1.59.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, August 7th. The health services provider reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.06. LHC Group had a return on equity of 8.83% and a net margin of 4.20%. The firm had revenue of $517.84 million during the quarter, compared to the consensus estimate of $524.24 million. During the same quarter in the prior year, the company earned $0.84 EPS. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, research analysts predict that LHC Group, Inc. will post 4.34 EPS for the current fiscal year.

In other LHC Group news, COO Donald Dwayne Stelly sold 3,306 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $115.87, for a total value of $383,066.22. Following the completion of the sale, the chief operating officer now owns 98,267 shares in the company, valued at approximately $11,386,197.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Ronald T. Nixon sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $117.20, for a total value of $1,406,400.00. Following the completion of the sale, the director now owns 29,100 shares of the company’s stock, valued at approximately $3,410,520. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,821 shares of company stock valued at $5,260,853. 5.20% of the stock is owned by corporate insiders.

Several research analysts have weighed in on the company. Jefferies Financial Group upped their target price on LHC Group from $125.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, May 9th. Oppenheimer upped their target price on LHC Group from $125.00 to $146.00 and gave the stock an “outperform” rating in a research report on Friday, August 9th. Royal Bank of Canada set a $135.00 target price on LHC Group and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group set a $133.00 target price on LHC Group and gave the stock a “buy” rating in a research report on Friday, May 10th. Finally, BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 2nd. Three analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $126.73.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Featured Article: What is the S&P 500 Index?

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.